Our findings demonstrated a positive correlation between TSP4 overexpression and LNM in BLCA, suggesting that TSP4 could possibly serve as a novel therapeutic target for the prevention of lymphatic dissemination in BLCA. The gene discussed is THBS4; the disease is bladder transitional cell carcinoma.